Media

Support Of Industry Underscores Pro-Business Commitment
Washington, D.C. (September 22, 2014) – BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO...

Press Releases

Feb 15 2001
WASHINGTON, D.C. (February 15, 2001) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
Feb 14 2001
WASHINGTON, D.C. (February 14, 2001) – U.S. Sen. Tim Hutchinson (R-Arkansas) and Newt Gingrich, former Speaker of the U.S. House of Representatives, will be...
Feb 12 2001
WASHINGTON, D.C. (February 12, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on...
Feb 1 2001
WASHINGTON, D.C. (February 1, 2001) – Following recent announcements by certain groups of plans to clone human beings, the Biotechnology Industry Organization...
Feb 1 2001
The Honorable George W. BushPresident of the United StatesThe White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: Recently certain...
Jan 30 2001
WASHINGTON, DC (January 30, 2001) –Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on President...
Jan 25 2001
WASHINGTON, D.C. (January 25, 2001) – The BiotechnologyIndustry Organization’s (BIO) CEO & Investor Conference next month in New York will showcase the...
Jan 17 2001
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding a notice of an FDA proposed rule...
Jan 17 2001
WASHINGTON, D.C. (January 17, 2001) -- Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the U.S....


Biotechnology News

October 20, 2014

BOSTON--(BUSINESS WIRE)--Today IBC Life Sciences, is pleased to kick off the 2014 edition of BioProcess International Conference & Exhibition, the world’s largest...

October 20, 2014

EVRY, France--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) (Alternext Paris: ALGBE), the industrial biology company that develops sustainable routes...

October 20, 2014

MALVERN, Pa.--(BUSINESS WIRE)--Phlexglobal, the specialist provider of innovative Trial Master File (TMF) and electronic Trial Master File (eTMF) expertise, solutions and...

October 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company, announced today that the Food and Drug Administration (FDA) has approved the inclusion of efficacy and safety...

October 20, 2014

HALIFAX, Nova Scotia--(BUSINESS WIRE)--The opening reception for BioPort Atlantic 2014, where Atlantic Canada’s leaders in life sciences meet, kicks off today. The full...